Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Journal of Neuroimmunology|May 16, 2018
Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10 years post chemotherapy using machine learningAshley M Henneghan, Oxana Palesh, Michelle Harrison, et al.
Nursing Research|December 30, 2021
Health Promotion, Functional Abilities, and Quality of Life Before and During COVID-19 in People With Multiple SclerosisHeather Becker, Alexa K Stuifbergen, Sungju Lim, et al.
Network Neuroscience (Cambridge, Mass.)|September 15, 2018
Functional and structural connectome properties in the 5XFAD transgenic mouse model of Alzheimer's diseaseShelli R Kesler, Paul Acton, Vikram Rao, et al.
Research Square|November 24, 2025
Temporal dysregulation of PPARG-PRKAG2 co-expression in gray matter: Implications for cognitive decline and intervention targets in type 2 diabetesShelli R Kesler, Kimberly A Lewis, Heather Cuevas, et al.
Neuropsychological Rehabilitation|July 1, 2011
Changes in frontal-parietal activation and math skills performance following adaptive number sense training: preliminary results from a pilot studyShelli R Kesler, Kristen Sheau, Della Koovakkattu, et al.
JMIR Cancer|May 25, 2022
Identifying Themes for Assessing Cancer-Related Cognitive Impairment: Topic Modeling and Qualitative Content Analysis of Public Online CommentsShelli R Kesler, Ashley M Henneghan, Whitney Thurman, et al.
Frontiers in Aging Neuroscience|September 11, 2014
Neural correlates of cognitive intervention in persons at risk of developing Alzheimer's diseaseS M Hadi Hosseini, Joel H Kramer, Shelli R Kesler
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 5, 2017
Probability of Alzheimer's disease in breast cancer survivors based on gray-matter structural network efficiencyShelli R Kesler, Vikram Rao, William J Ray, et al.
Frontiers in Psychology|March 7, 2022
Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 SurvivorsAshley M Henneghan, Kimberly A Lewis, Eliana Gill, et al.
Neurogenetics|March 12, 2009
The impact of spermine synthase (SMS) mutations on brain morphologyShelli R Kesler, Charles Schwartz, Roger E Stevenson, et al.
Pageof 13